Schizophrenia & Other Psychotic Disorders
From the Journals
‘Landmark’ schizophrenia drug in the wings?
“The results showing robust therapeutic efficacy of a non–dopamine-targeting antipsychotic drug is an important milestone,” said Dr. Jeffrey A....
Conference Coverage
When should a patient’s violent thoughts trigger your action?
A good violence risk assessment can help you mitigate the potential for one of your patients to carry out harm to self or to others.
From the Editor
Treatment resistance is a myth!
Rapid advances in understanding the many etiologies and subtypes of the heterogenous mood and psychotic disorders are invalidating the notion of...
From the Journals
PTSD prevalent in survivors of severe COVID-19
The results are “in line” with findings reported in other events, such as Hurricane Katrina of 2005, and the 2011 Japan earthquake and tsunami.
Conference Coverage
Inflammatory immune findings likely in acute schizophrenia, MDD, bipolar
“Some of this activation decreases with effective acute treatment of the disorder,” said Dr. Mark Hyman Rapaport.
From the Journals
Placenta’s role in schizophrenia ‘bigger than we imagined'
“The holy grail would be to identify ... who is at maximum risk for schizophrenia from very early in life,” said Dr. Daniel R. Weinberger.
Conference Coverage
Clozapine still underused in refractory schizophrenia
Try one or two antipsychotics, and “if the patient is responding poorly they should go on to clozapine,” said Dr. Stephen R. Marder.
Commentary
Inpatient psychiatrist? Maybe I’ll be a vaccinator instead
“Nobody was upset with me for involuntarily holding them against their will,” said Dr. Ashley Stone. “They merely wanted a shot.”
Conference Coverage
Delusional infestation surges during COVID-19 pandemic
Experts weigh in on management of this challenging disorder marked by tenacious false beliefs.
From the Journals
‘Alarming finding’ in schizophrenia patients with COVID-19
Patients diagnosed with schizophrenia were two to three times more likely to die of COVID-19 if they contracted the disease.
Evidence-Based Reviews
Long-acting injectable antipsychotics during COVID-19
How to determine if your patient should continue an LAI, and how to do so safely.